176 related articles for article (PubMed ID: 25714613)
41. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation.
Shimizu T; Cai S; Tomioka H
Cytokine; 2005 Apr; 30(1):7-13. PubMed ID: 15784407
[TBL] [Abstract][Full Text] [Related]
42. The role of innate immune responses in autoimmune disease development.
Waldner H
Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
[TBL] [Abstract][Full Text] [Related]
43. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
[No Abstract] [Full Text] [Related]
44. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.
Granucci F; Zanoni I; Feau S; Ricciardi-Castagnoli P
EMBO J; 2003 Jun; 22(11):2546-51. PubMed ID: 12773371
[TBL] [Abstract][Full Text] [Related]
45. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
46. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
[TBL] [Abstract][Full Text] [Related]
47. Modulation of T cell and innate immune responses by retinoic Acid.
Raverdeau M; Mills KH
J Immunol; 2014 Apr; 192(7):2953-8. PubMed ID: 24659788
[TBL] [Abstract][Full Text] [Related]
48. Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy.
Yang D; Dai F; Yuan M; Zheng Y; Liu S; Deng Z; Tan W; Chen L; Zhang Q; Zhao X; Cheng Y
Front Immunol; 2021; 12():689181. PubMed ID: 34531852
[TBL] [Abstract][Full Text] [Related]
49. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
50. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
[TBL] [Abstract][Full Text] [Related]
51. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
[TBL] [Abstract][Full Text] [Related]
52. Immunoregulatory disturbances in human and murine systemic lupus erythematosus.
Santoro TJ
Clin Exp Rheumatol; 1986; 4(2):169-74. PubMed ID: 2426025
[No Abstract] [Full Text] [Related]
53. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease.
Horwitz DA; Gray JD; Ohtsuka K
Microbes Infect; 1999 Dec; 1(15):1305-11. PubMed ID: 10611759
[TBL] [Abstract][Full Text] [Related]
54. Cellular immune function in rheumatic disease.
Dehoratius RJ
Hum Pathol; 1983 May; 14(5):442-5. PubMed ID: 6220955
[TBL] [Abstract][Full Text] [Related]
55. Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy.
Villar VH; Subotički T; Đikić D; Mitrović-Ajtić O; Simon F; Santibanez JF
Adv Exp Med Biol; 2023; 1408():309-328. PubMed ID: 37093435
[TBL] [Abstract][Full Text] [Related]
56. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.
Gaignage M; Zhang X; Stockis J; Dedobbeleer O; Michiels C; Cochez P; Dumoutier L; Coulie PG; Lucas S
Cancer Immunol Immunother; 2022 Aug; 71(8):1851-1862. PubMed ID: 34973084
[TBL] [Abstract][Full Text] [Related]
57. Carboxypeptidase D: a novel TGF-beta target gene dysregulated in patients with lupus erythematosus.
Hoff NP; Degrandi D; Hengge U; Pfeffer K; Wurthner JU
J Clin Immunol; 2007 Nov; 27(6):568-79. PubMed ID: 17641957
[TBL] [Abstract][Full Text] [Related]
58. [Suppressor cells - the basis of the immunopathogenesis of cancer].
Kozlov VA
Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899
[TBL] [Abstract][Full Text] [Related]
59. [Role of T- and B-cell immunity in the pathogenesis of cancer].
Savchenko AA; Borisov AG; Kudryavtsev IV; Moshev AV
Vopr Onkol; 2015; 61(6):867-75. PubMed ID: 26995973
[TBL] [Abstract][Full Text] [Related]
60. Inborn resistance of ice to orthomyxoviruses.
Haller O
Curr Top Microbiol Immunol; 1981; 92():25-52. PubMed ID: 6171385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
